Report Calls for Sustained Funding for Global Health Emergencies

FILE - Laboratory technicians develop a technology to mass produce Ebola vaccine, Aug. 14, 2014.

voanews.com - by William Eagle - May 7, 2016

The United States remains by far the most important source of funds for medical research and development for scores of diseases well-known to the developing world.

According to the latest available data from the independent research group Policy Cures, global donors contributed over $2 billion in public funding for research into what the medical community calls neglected diseases. The U.S. government accounted for over 70 percent of the amount.

But a new report from the Global Health Technologies Coalition, a group of nonprofits that promotes creation of vaccines and other tools to improve global health, says that over the past five years, funding has largely been flat. This is in contrast to the first decade of the 21st century, which saw a doubling of financial support. . . .

. . . The GHTC report asks the U.S. government to encourage private sector involvement in R&D with prizes, small-business innovation awards, tax credits and other incentives. It also recommends improved cooperation among the seven U.S. agencies involved in global health.

(READ COMPLETE ARTICLE)

GHTC - Achieving a bold vision for global health: Policy solutions to advance global health R&D
http://www.ghtcoalition.org/annual-reports-item/achieving-a-bold-vision-for-global-health-policy-solutions-to-advance-global-health-r-d

GHTC Annual Policy Report - Achieving a bold vision for global health: Policy solutions to advance global health R&D (24 page .PDF report)
http://www.ghtcoalition.org/pdf/Achieving-a-bold-vision-for-global-health-Policy-solutions-to-advance-global-health-R-D.pdf